...
首页> 外文期刊>BMC Psychiatry >Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid
【24h】

Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid

机译:关于抗透视核素的决定:对患者经验的定性研究和决策援助的发展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Shared decision making is a widely accepted standard of patient-centred care that leads to improved clinical outcomes, yet it is commonly underutilised in the field of mental health. Furthermore, little is known regarding patient decision making around antipsychotic medication, which is often poorly adhered to. We aim to explore psychiatric patients’ experiences of antipsychotic medication decision making in order to develop a patient decision aid to promote shared decision making. Focus groups were conducted with patients with chronic psychotic illnesses (n?=?20) who had previously made a decision about taking or changing antipsychotic medication. Transcripts were coded and analysed for thematic content and continued until thematic saturation. These themes subsequently informed the development of a decision aid with the help of expert guidance. Further patient input was sought using the think aloud method (n?=?3). Twenty-three patients participated in the study. Thematic analysis revealed that ‘adverse effects’ was the most common theme identified by patients surrounding antipsychotic medication decision-making followed by ‘mode and time of administration’, ‘symptom control’ and ‘autonomy’. The final decision aid is included to provoke further discussion and development of such aids. Patients commonly report negative experiences of antipsychotic medication, in particular side-effects, which remain critical to future decision making around antipsychotic medication. Clinical encounters that increase patient knowledge and maximise autonomy in order to prevent early negative experiences with antipsychotic medication are likely to be beneficial.
机译:共享决策是广泛接受的患者中心护理标准,导致改善临床结果,但它通常在心理健康领域不足。此外,关于抗精神病药体的患者决策,甚至很少知道,这通常是粘附的不良症状。我们的目标是探讨精神病患者的抗精神病药药物决策经验,以便制定患者决策援助,以促进共享决策。焦点小组是用慢性精神病患者进行的(N?=?20)进行的,他先前做过关于服用或改变抗精神病药的决定。编码并分析转录物以进行主题含量,并持续直至主题饱和度。这些主题随后在专家指导的帮助下了解决策援助。使用思想大声方法寻求进一步的患者输入(n?=?3)。二十三名患者参加了这项研究。专题分析显示“不利影响”是抗精神病药决策患者鉴定的最常见主题,其次是“行政模式和时间”,“症状控制”和“自主权”。包括最终决策援助,以引发此类艾滋病的进一步讨论和发展。患者通常报告抗精神病药药物的负面经验,特别是副作用,这对未来抗精神病药的决策仍然至关重要。增加患者知识并最大限度地提高自治的临床偶然,以防止抗精神病药药物的早期负面经历可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号